Pathways to Diagnosis for Prostate Cancer in Black and White Men
Author Information
Author(s): Metcalfe C, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F, Corbishley C, Gillatt D, Kirby R, Muir G, Nargund V, Popert R, Persad R, Ben-Shlomo Y
Primary Institution: University of Bristol
Hypothesis
Does access to diagnostic services explain the higher incidence of prostate cancer in Black men compared to White men?
Conclusion
The study found no evidence that Black men have poorer access to diagnostic services, and differences in diagnosis pathways are insufficient to explain the higher rate of prostate cancer in Black men.
Supporting Evidence
- Black men were diagnosed an average of 5.1 years younger than White men.
- Both groups had comparable knowledge of prostate cancer.
- Black men were more likely to be referred for diagnostic investigation by a hospital department.
Takeaway
Black men are diagnosed with prostate cancer about 5 years earlier than White men, but both groups have similar access to healthcare.
Methodology
This was a population-based retrospective cohort study that reviewed hospital records and used questionnaires to assess demographic factors and diagnostic pathways.
Potential Biases
There may be bias in the self-reported data from questionnaires, as those who did not return them may have had different healthcare access.
Limitations
The study is limited by its retrospective design and reliance on medical records and self-reported data.
Participant Demographics
The study included Black and White men diagnosed with prostate cancer in southern England, with a focus on socioeconomic status and knowledge of prostate cancer.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI: 4.2–5.9 years
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website